Till Örebro universitet

oru.seÖrebro universitets publikationer
Driftmeddelande
För närvarande är det driftstörningar. Felsökning pågår.
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Etiology and outcomes of amputation in patients with peripheral artery disease in the EUCLID trial
CPC Clinical Research, Aurora CO, USA; Division of Vascular Surgery, Department of Surgery, University of Colorado Department of Surgery, Aurora CO, USA .ORCID-id: 0000-0001-9410-4094
CPC Clinical Research, Aurora CO, USA; Division of Vascular Surgery, Department of Surgery, University of Colorado Department of Surgery, Aurora CO, USA .
Division of Endocrinology, Metabolism, and Diabetes, University of Colorado School of Medicine, Aurora CO, USA.
CPC Clinical Research, Aurora CO, USA.
Visa övriga samt affilieringar
2022 (Engelska)Ingår i: Journal of Vascular Surgery, ISSN 0741-5214, E-ISSN 1097-6809, Vol. 75, nr 2, s. 660-670e3Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Objective: Amputation remains a frequent and feared outcome in patients with peripheral artery disease (PAD). Although typically characterized as major or minor on the extent of tissue loss, the etiologies and outcomes after amputation by extent are not well-understood. In addition, emerging data suggest that the drivers and outcomes of amputation in patients with PAD may differ in those with and without diabetes mellitus (DM).

Methods: The EUCLID trial randomized 13,885 patients with symptomatic PAD, including 5345 with concomitant diabetes, to ticagrelor or clopidogrel and followed them for long-term outcomes. Amputations were prospectively reported by trial investigators. Their primary and contributing drivers were adjudicated using safety data, including infection, ischemia, or multifactorial etiologies. Outcomes following major and minor amputations were analyzed, including recurrent amputation, major adverse limb events, adverse cardiovascular events, and mortality. Multivariable logistic regression models were used to identify independent predictors of minor amputations. Analyses were performed overall and stratified by the presence or absence of DM at baseline.

Results: Of the patients randomized, 398 (2.9%) underwent at least one lower extremity nontraumatic amputation, for a total of 511 amputations (255 major and 256 minor) over a median of 30 months. A history of minor amputation was the strongest independent predictor for a subsequent minor amputation (odds ratio, 7.29; 95% confidence interval, 5.17-10.30; P <.001) followed by comorbid DM (odds ratio, 4.60; 95% confidence interval, 3.16-6.69; P <.001). Compared with patients who had a major amputation, those with a minor amputation had similar rates of subsequent major amputation (12.2% vs 13.6%), major adverse limb events (15.1% vs 14.9%), and major adverse cardiovascular events (17.6% vs 16.3%). Ischemia alone was the primary driver of amputation (51%), followed by infection alone (27%), and multifactorial etiologies (22%); however, infection was the most frequent driver in those with DM (58%) but not in those without DM (15%).

Conclusions: Outcomes after amputation remain poor regardless of whether they are categorized as major or minor. The pattern of amputation drivers in PAD differs by history of DM, with infection being the dominant etiology in those with DM and ischemia in those without DM. Greater focus is needed on the prognostic importance of minor amputation and of the multifactorial etiologies of amputation in PAD. Nomenclature with anatomical description of amputations and eliminating terms "major" or "minor" would seem appropriate.

Ort, förlag, år, upplaga, sidor
Elsevier, 2022. Vol. 75, nr 2, s. 660-670e3
Nyckelord [en]
Amputation, Diabetes mellitus, Infection, Lower extremity, Peripheral artery disease
Nationell ämneskategori
Kirurgi
Identifikatorer
URN: urn:nbn:se:oru:diva-97370DOI: 10.1016/j.jvs.2021.08.096ISI: 000746023000038PubMedID: 34597783Scopus ID: 2-s2.0-85122984303OAI: oai:DiVA.org:oru-97370DiVA, id: diva2:1636186
Anmärkning

Funding agencies:

National Institutes of Health/National Center for Advancing Translational Sciences Colorado CTSI UL1 TR002535

American Heart Association Strategically Focused Research Network in Vascular Disease 18SFRN3390085 18SFRN33960262

Tillgänglig från: 2022-02-09 Skapad: 2022-02-09 Senast uppdaterad: 2024-03-05Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltextPubMedScopus

Person

Norgren, Lars

Sök vidare i DiVA

Av författaren/redaktören
Govsyeyev, NicholasNorgren, Lars
Av organisationen
Institutionen för humaniora, utbildnings- och samhällsvetenskap
I samma tidskrift
Journal of Vascular Surgery
Kirurgi

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 65 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf